The effects of empagliflozin in patients with type 1 diabetes: Results of a 12-week, double-blind, randomized, placebo-controlled clinical trial
Authors
- Maryam Ghavami (ORCID: https://orcid.org/0000-0003-1232-8938)
- Alireza Ostadrahimi (ORCID: https://orcid.org/0000-0002-1179-4833)
- Naimeh Mesri Alamdari (ORCID: https://orcid.org/0000-0003-2563-8193)
- Helda Tutunchi (ORCID: https://orcid.org/0000-0002-4795-1757)
- Mostafa Najafipour (ORCID: https://orcid.org/0000-0002-9831-933X)
- Zohreh Razaghi
- Farzad Najafipour (ORCID: https://orcid.org/0000-0003-1950-0702)
Institutions
- Tabriz University of Medical Sciences (IR)
- Ardabil University of Medical Sciences (IR)
Publication Details
- Journal
- Health Promotion Perspectives
- Published
- 2024-12-30
- DOI
- https://doi.org/10.34172/hpp.42486
- Citations
- 2
- Primary Topic
- Diabetes and associated disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.10
Funders
- Tabriz University of Medical Sciences
- University of Tabriz